ArabicChineseEnglishFrenchRussianSpanish
WHO home
All WHO This site only
 

HIV/AIDS

  WHO > Programmes and projects > HIV/AIDS > AIDS medicines and diagnostics service (AMDS)
printable version

Global price reporting mechanism

Access the database

Global price reporting mechanism


what is the Global price reporting mechanism (gprm)

GPRM is a web-based transaction database launched by the AMDS in April 2005. It contains information on transaction prices and quantities of antiretroviral medicines (ARVs), tuberculosis and malaria drugs and commodities purchased by HIV/AIDS, Malaria and Tuberculosis Programmes in low and middle income countries. It complements reports of price quotes from pharmaceutical companies, as well as smaller sets of transaction prices published by other sources.

Related
GPRM user guide [pdf 1.07Mb]

GPRM summary reports
June 2009 [pdf 372kb]

October 2008 [pdf 1.07Mb]

July 2008 [pdf 747kb]

February 2008 [pdf 263kb]

October 2007 [pdf 187kb]

July 2007 [pdf 337kb]

March 2007 [pdf 206kb]

August 2006 [pdf 623kb]

April 2006 [pdf 133kb]

September 2005 [pdf 1.33Mb]

Weighted average prices of ARVs in low- and middle-income countries in 2005 [pdf 96kb]


It also serves as a price monitoring tool that monitors and shares prices information of ARV, tuberculosis and malaria drugs and commodities to help treatment programmes in countries to compare and choose optimal pricing.

Currently, the GPRM offers prices of ARVs, anti tuberculosis and Malaria drugs purchased and supplied by various procuring agencies for different countries, based on information by The William J. Clinton Foundation (CHAI), The Crown Agent, The Global Drug Facility (GDF), The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), The Global Malaria Programme (GMP), The International Dispensary Association (IDA HIV/AIDS), USAID/Deliver), Mission Pharma, Management Sciences for Health (MSH), The Partnership for Supply Chain Management (PFSCMS), The United Nations Development Programme (UNDP), The United Nations Population Fund (UNFPA), The United Nations Children's Fund (UNICEF), UNITAID and The WHO/Contracting and Procurement Service (WHO/CPS).

Purpose

As treatment for people living with HIV/AIDS in developing countries increases, countries are facing the huge challenge of continuously supplying affordable ARV drugs to enable life-long treatment of AIDS. Other challenges faced by countries include: constraints by high prices, and limited budgets. Deciding which ARV is the best to procure is often a matter of guess work or a question of trial and error, without a wide range of information on available prices. With this tool, users can compare prices not only within their own countries but also from neighbouring markets and regions.

how to access

To access GPRM, please click on this link. You can also access periodic reports in the side column. To access the GPRM user guide, please click on this link.

contact

The AMDS seeks to increase its collaboration with all organizations involved in ARV, Tuberculosis and Malaria drug procurement and supply, including Ministries of Health and Drug Regulatory Agencies to expand the information base for the AMDS clearinghouse, which hosts the 'Global Price Monitoring Mechanism'. For more information or suggestions, you can contact AMDS at amds@who.int.

AMDS main page